LOGIN
ID
PW
MemberShip
2025-09-04 13:01
All News
Policy
Company
Product
Opinion
InterView
°Ë»ö
Dailypharm Live Search
Close
Roche 2018 Annualreport
Roche 2018 Annualreport
2019-12-23
NOVARTIS 2018 Annualreport
NOVARTIS 2018 Annualreport
2019-12-23
2018 Multinational Pharma Sales
2018 Multinational Pharma Sales
2019-11-15
Risk-Sharing Agreements in the EU: A Systematic Review
Risk-Sharing Agreements in the EU: A Systematic Review of Major Trends
2019-11-15
Managed Entry Agreements for
Managed Entry Agreements for Oncology Drugs
2019-11-15
OPINION
[Reporter¡¯s View] Be aware, be prepared
Reporter's view |
Eo, Yun-Ho
[Reporter's View] New opportunities have emerged for K-Bio
Reporter's view |
Son, Hyung Min
[Reporter's View] Innovativeness and trust in healthcare AI
Reporter's view |
Whang, byung-woo
INTERVIEW
Dong-A ST launches Sterlara biosimilar Imuldosa in the US
V-olet challenges to become a blockbuster fat-destroying inj
Kim Seul-ki, PM of Daewoong Pharmaceutical's Nabota Business Team
'Viatris will lead market with innovation and leadership'
Bill Schuster, Representative Director & Country Manager of Viatris Korea
"Livtencity offers new CMV trt for transplant patients"
Dr. Sang-Oh Lee, professor at Seoul Asan Medical Center's Department of Infectious Diseases
¡®SGLT2i+TZD promising for diabetics with fatty liver risk¡¯
Cheol-Young Park, Professor of Endocrinology at Kangbuk Samsung Hospital
Data
Roche 2018 Annualreport
Roche 2018 Annualreport
NOVARTIS 2018 Annualreport
NOVARTIS 2018 Annualreport
2018 Multinational Pharma Sales
2018 Multinational Pharma Sales
MOST READ
1
COVID-19 response more important for high-risk groups
2
"MFDS' data-based drug shortage response"
3
Patent suits active to release Rinvoq generics
4
CKD says, "New ADC drug enters first clinical trials"
5
How will fate fare for Roche¡¯s two anticancer drugs?
6
'Prevenar 20' now available at general hospitals
7
[Reporter's View] New opportunities have emerged for K-Bio
8
Moderna¡¯s latest variant-targeted COVID-19 vaccine approved
9
[Reporter¡¯s View] Be aware, be prepared
10
Capvaxive release imminent in the pneumococcal vaccine mkt